- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-TDP-43 (human specific)
TDP-43 (human specific) Monoclonal Antibody for FC, IHC, IP, WB, ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain et plus (1)
Applications
WB, IP, IHC, FC, CoIP, ELISA
Conjugaison
Non conjugué
CloneNo.
6H6E12
N° de cat : 60019-2-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules LNCaP, cellules HEK-293, cellules HeLa, cellules HepG2, cellules Jurkat, cellules K-562 |
Résultats positifs en IP | cellules K-562 |
Résultats positifs en IHC | tissu de gliome humain, tissu cérébral humain (DLFT-U), tissu de cancer du pancréas humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Résultats positifs en cytométrie | cellules MCF-7 |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochimie (IHC) | IHC : 1:5000-1:20000 |
Flow Cytometry (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 52 publications below |
IHC | See 26 publications below |
IP | See 4 publications below |
CoIP | See 2 publications below |
Informations sur le produit
60019-2-Ig cible TDP-43 (human specific) dans les applications de WB, IP, IHC, FC, CoIP, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Réactivité citée | Humain, cellule de levure |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | Protéine recombinante |
Nom complet | TAR DNA binding protein |
Masse moléculaire calculée | 43 kDa |
Poids moléculaire observé | 43 kDa |
Numéro d’acquisition GenBank | BC001487 |
Symbole du gène | TARDBP |
Identification du gène (NCBI) | 23435 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS avec azoture de sodium à 0,1 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Transactivation response (TAR) DNA-binding protein of 43 kDa (also known as TARDBP or TDP-43) was first isolated as a transcriptional inactivator binding to the TAR DNA element of the HIV-1 virus. Neumann et al. (2006) found that a hyperphosphorylated, ubiquitinated, and cleaved form of TARDBP, known as pathologic TDP-43, is the major component of the tau-negative and ubiquitin-positive inclusions that characterize amyotrophic lateral sclerosis (ALS) and the most common pathological subtype of frontotemporal lobar degeneration (FTLD-U). Various forms of TDP-43 exist, including 18-35 kDa of cleaved C-terminal fragments, 45-50 kDa phospho-protein, 55 kDa glycosylated form, 75 kDa hyperphosphorylated form, and 90-300 kDa cross-linked form. (PMID: 17023659,19823856, 21666678, 22193176). 60019-2-Ig is a mouse monoclonal antibody recognizing the cleavage product of 20-30 kDa in addition to the native and phosphorylated forms of TDP-43. Immunohistochemical analyses of TDP-43 using this antibody detect both normal diffuse nuclear staining and insoluble inclusions in pathologic tissues. Notably this antibody only recognizes human TDP-43 but not reacts with mouse or rat TDP-43.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for TDP-43 (human specific) antibody 60019-2-Ig | Download protocol |
IHC protocol for TDP-43 (human specific) antibody 60019-2-Ig | Download protocol |
IP protocol for TDP-43 (human specific) antibody 60019-2-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Nature Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. | ||
Nat Med The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. | ||
Nat Neurosci TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration. | ||
Nat Neurosci TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Lidiya (Verified Customer) (05-26-2022) | The antibody works great! Antibody was used for WB in Neuroblastoma cell lines (SK-N-BE(2)C and IMR32) with HRP-conjugated secondary. Antibody was also used for a Proximity Ligation Assay to assess interaction with another protein in SK-N-BE(2)C cells. 1:50 of antibody was used for this assay.
|
FH David (Verified Customer) (01-13-2020) | Great antibody for several applications. Works nicely for immunoblot and immunofluourescence. Can also be used for RNA immunoprecipitation.
|